In this issue:
Platelet transfusion pre-CVC placement in thrombocytopenia
SARS-COV-2 vaccination in the first year after allogeneic BMT
Antibiotic exposure and acute GVHD after allogeneic BMT
Double vs. single strategy for preventing transfusion-transmitted CMV
Magrolimab + azacitidine in higher-risk myelodysplastic syndrome
Sovleplenib for primary ITP
Alternative donor BMT with posttransplant cyclophosphamide for severe aplastic anaemia
Responses after thrombopoietin receptor agonist discontinuation in primary ITP
Prognostic value of blood biomarkers in steroid-refractory/dependent acute GVHD
Impact of DTI in newly diagnosed mantle cell lymphoma
Please login below to download this issue (PDF)